Search

FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act. By Melissa Schiller Jonathan Havens, co-chair of the Cannabis...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice, and co-chair of the Firm's Food, Beverage and Agribusiness Practice, spoke at the Food and Drug Law Institute's 2022 Legal and Practical Issues in Cannabis Regulation Conference on May 25, 2022. Jonathan's topic was "Facilitating...

FACILITATING STAKEHOLDER COLLABORATION TO IMPROVE FUTURE CANNABIS REGULATION Jonathan Havens, Co-Chair of the Firm's Cannabis Law Practice, and Co-Chair of the Firm's Food, Beverage and Agribusiness Practice, will be speaking at the Food and Drug Law Institute's 2022 Legal and Practical Issues in...

Greg Rapisarda, co-chair of the Firm's Telecommunications Practice, attended Connect (X), a conference hosted by Wireless Infrastructure Association from May 23, 2022 to May 26, 2022. Connect (X) showcases the leaders in 5G infrastructure: innovative technology, supporting professional services, and...

Greg Rapisarda, Co-Chair of the Firm's Telecommunications Practice, will be attending Connect (X), a conference hosted by Wireless Infrastructure Association. Connect (X) showcases the leaders in 5G infrastructure: innovative technology, supporting professional services, and a partner ecosystem that...

In just two months, from mid-November 2020 to mid-January 2021, Saul Ewing LLP's Cannabis Law Practice assisted clients in closing transactions with a combined deal value of more than $520 million. We served as: U.S. counsel to Canaccord Genuity Corp., lead underwriter of an overnight marketed...